Entasis Therapeutics Holdings Inc
(ETTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 12-2016 | |
| Sales | 5,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 5,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 12,027 | 11,768 | 0 | 8,513 | 0 |
| Operating Income | -7,027 | -11,768 | N/A | -8,513 | N/A |
| Other Income | 1,766 | 1,101 | 0 | 189 | 0 |
| Pre-tax Income | -5,261 | -10,667 | 0 | -8,324 | 0 |
| Income Tax | 472 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -5,733 | -10,667 | N/A | -8,324 | N/A |
| Net Income | $-5,733 | $-10,667 | $N/A | $-8,324 | $N/A |
| EPS Basic Total Ops | -453.60 | -844.01 | N/A | -5,106.75 | N/A |
| EPS Basic Continuous Ops | -453.60 | -820.54 | N/A | -5,106.75 | N/A |
| EPS Diluted Total Ops | -453.60 | -844.01 | N/A | -5,106.75 | N/A |
| EPS Diluted Continuous Ops | -453.60 | -820.54 | N/A | -5,106.75 | N/A |
| EBITDA(a) | $-6,994 | $-11,712 | $N/A | $-8,513 | $N/A |